Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Mena, Raul, M.D.
East Valley Hematology and Oncology Group

      This research study measures the safety and efficacy of the combination of three drugs that
      are approved, Nipent, Rituxan and Cytoxan in the treatment of Chronic Lymphocytic Leukemia
      (CLL). These drugs are being given together for investigational purposes as the specific
      combination of these three drugs has not been approved for treatment of CLL by the FDA.
    
Drug